Wearing Face Mask Reduces Risk for Symptoms of Respiratory Infection
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 31, 2024 -- Wearing a surgical mask in public spaces is associated with a reduced risk for self-reported symptoms consistent with a respiratory infection, according to a study published online July 24 in The BMJ.
Runar Barstad Solberg, Ph.D., from the Norwegian Institute of Public Health in Oslo, and colleagues conducted a pragmatic randomized superiority trial involving 4,647 adults to assess the personal protective effects of wearing versus not wearing surgical face masks in public spaces on self-reported respiratory symptoms. Participants were assigned to an intervention arm (2,371 participants) or control arm (2,276 participants); the intervention arm was assigned to wear a surgical face mask in public spaces during a 14-day period.
The researchers identified 163 events of self-reported symptoms consistent with respiratory infection reported in the intervention arm and 239 events in the control arm (8.9 versus 12.2 percent), with a marginal odds ratio of 0.71 favoring the face mask intervention (absolute risk difference, −3.2 percent). No significant effect was seen in terms of self-reported or registered COVID-19 infection.
"The effect size was moderate, but wearing a face mask is a simple intervention with low burden and of relatively low cost and is one of several public health and social measures that may be worth considering for reducing the spread of respiratory infections," the authors write.
One author is named inventor on a patent application related to vaccine development.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Widespread Decline Seen in MMR Vaccination Rates After COVID-19
THURSDAY, June 5, 2025 -- A widespread decrease in measles-mumps-rubella (MMR) vaccination rates was seen after the COVID-19 pandemic, according to a research letter published...
Cardiorespiratory Effects of Smoke Fine Particulate Matter From Wildfires Can Persist for Months
THURSDAY, June 5, 2025 -- The cardiorespiratory effects of smoke fine particulate matter (PM2.5), a primary wildfire emission that can spike for months after a wildfire begins...
Total Number of Excess Deaths >14.7 Million in U.S. in 1980 to 2023
THURSDAY, May 29, 2025 -- There were 14,735,913 excess deaths in the United States during 1980 to 2023 compared with other high-income countries (HICs), according to a research...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.